Option strategists at Goldman Sachs are recommending buying Vertex Pharmaceuticals (Nasdaq: VRTX) July 55 calls on three important catalysts and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE